Background: Our previous studies have shown that the majority of African women were infected with multiple HIV-1 genetic variants, while in the remaining women only a single viral genotype was detected early in infection. Infection with multiple viral variants was associated with higher plasma HIV-1 RNA levels and faster CD4 T-cell decline.
Introduction
The majority of HIV-1 infected women from Africa who have been examined acquired a genetically complex HIV-1 population from their partner [1] [2] [3] [4] . The remaining approximately 40% of women from Africa were infected with a single viral variant. Several viruses from one contact infected the women who had multiple viruses early in infection [1, 3] . Interestingly, women who were infected with multiple variants had higher HIV-1 plasma viral loads and faster decline in absolute CD4 T-cell counts than women who acquired a single viral genotype [4] . Thus, factors that promote infection by several HIV-1 variants may predispose those infected individuals to faster disease progression.
It is not known whether there are specific factors present at the time of exposure that influence the genetic complexity of the sexually transmitted HIV-1 population. If genetic complexity early in infection is indicative of an increased susceptibility of the host, then factors that augment the risk for acquiring HIV-1 may also increase the likelihood that different viral variants will establish a productive infection. The presence of sexually transmitted diseases (STD) around the time of transmission has been shown to increase the risk of HIV-1 acquisition [5] [6] [7] . The use of hormonal contraceptives (HC) at the time of infection has also been associated with an increased susceptibility to HIV-1 although this relationship has not been a consistent finding in all studies [8] [9] [10] [11] [12] [13] [14] . Differences in the frequency of monitoring and the rigor with which sexual behavior was assessed may account for the inconsistent results [15] . The associations that have been observed, however, suggest that STD and HC may alter virus-host interactions [5, 7, 16] , and thus they may also influence the breadth of viruses able to productively infect a host.
To elucidate factors associated with the acquisition of multiple viral variants, we prospectively studied female sex workers in Kenya before and after HIV-1 seroconversion. The subjects in this cohort were monitored frequently so that the time of HIV-1 acquisition could be estimated with precision. Behavioral, clinical and laboratory data were used to assess the relationship between the factors present at the time of infection and the genetic complexity of the infecting HIV-1 variants.
Methods

Subjects
HIV-1 seronegative sex workers were followed monthly, through HIV-1 acquisition, with a structured interview focusing on sexual behavior, contraceptive practices, and physical symptoms, a physical examination including a pelvic exam, and blood sample collection as described [8] . A date of infection was assigned for each subject based on results of prospective HIV-1 serological testing and retrospective testing for HIV-1 RNA of stored pre-seroconversion plasma [4] . To enhance our ability to define factors present at the time of HIV-1 acquisition, only women positive for HIV-1 RNA prior to seroconversion or with less than 1 year between the last negative HIV-1 serology and the first positive HIV-1 antibody test were selected for inclusion in the study.
Cofactors and viral diversity at the time of infection
Sexual behavior at the time of HIV-1 acquisition was based on an average calculated for each sexual exposure variable (number of sexual partners, number of sexual encounters, and the number of times condoms were used for those sexual encounters) from all visits during the 6 months prior to estimated infection date as described [8] . The methods for STD screening and syndrome diagnosis were as described previously [8] . The effect of a STD was estimated to persist for 15 days after treatment, and thus, genital tract infections (GTI) were defined as present at the time of HIV-1 acquisition if they were noted within the 15 days before or at the first clinic visit after the estimated HIV-1 infection day. The effects of HC were estimated to persist for 70 days after discontinuing use. Thus, a women's HC status was included if use was recorded within 70 days prior to or at the two visits flanking the calculated infection date. In addition, women who changed contraceptive methods during the 70 days prior to the calculated infection date were defined as being exposed to both contraceptive methods. A small number of women who changed their HC method between the two visits flanking the estimated infection date and had more than 70 days between the last visit and the estimated date of infection were excluded.
Genetic diversity in the proviral envelope gene sequences at the first visit after seroconversion was determined independently of the clinical data as described [4] .
Statistical analysis
Statistical analyses were conducted with the use of SPSS 10.0 (SPSS, Chicago, Illinois, USA) or EPI INFO 2000 (CDC, Atlanta, Georgia, USA). Pearson chi-square test, and multivariate linear and logistic regression models were used to estimate the associations between factors present at the time of infection and HIV-1 diversity.
Results
As described earlier, 89 (57%) of the 156 women had a heterogeneous virus, and the remaining 67 (43%) had a homogeneous virus early in infection [4] . There was no significant difference in the median interval from the estimated infection date to the collection day of the sample assayed for viral diversity for the women with multiple genotypes and those with a single genotype (Table 1) .
There was no significant difference between the two groups of women in the number of sex partners, sexual frequency, or in the percentage of times condoms were used during sexual encounters ( Table 1 ). The percentage of women who reported 100% condom use was similar in the women with heterogeneous genotypes (40%) compared to those with a homogeneous genotype (44%) (P ¼ 0.6).
Both abnormal vaginal discharge and cervicitis were associated with a significantly higher likelihood of acquiring multiple viral variants ( Table 2 ). We did not find an association between early viral diversity and the presence of any specific sexually transmitted microorganism. Subjects were further grouped as having any GTI if they were diagnosed with any STD and/or any genital tract syndrome at the time of estimated infection. Women infected with multiple HIV-1 genotypes had an approximately fivefold greater likelihood of having any GTI than women who acquired one HIV-1 genotype. Because the majority of GTI were diagnosed during the first clinic visit after HIV-1 acquisition, this may have included GTI that were acquired concurrently or after HIV-1 transmission. In a subgroup analysis in 29 women with documented GTI during the 15 days prior to the estimated HIV-1 acquisition date, there was a similar association between the presence of GTI and a heterogeneous virus popu-Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. Oral contraceptive pills and depo-medroxyprogesterone injections alone and HC in aggregate at the time of infection were significantly associated with acquiring multiple viral variants at or near seroconversion ( Table 2 ). In multivariate logistic regression analysis HC (OR, 2.7; 95% CI, 1.1-6.6; P ¼ 0.03) and the presence of any GTI (OR, 6.7; 95% CI, 1.9-23.9; P ¼ 0.004) remained independent predictors of early viral heterogeneity. In a subgroup analysis of the 62 women who had documented HIV-1 RNA prior to seroconversion, HC (OR, 3.0; 95% CI, 0.8-12.0; P ¼ 0.11) and the presence of any GTI (OR, 4.7; 95% CI, 0.9-26.0; P ¼ 0.08) showed a similar association with early viral diversity.
We have previously shown that the use of HC at the time of HIV-1 acquisition and infection with multiple HIV-1 genotypes was associated with a higher viral set point [4, 17] . After adjusting for HC use and the presence of any GTI, subjects infected with diverse viruses maintained a 0.44 log 10 copies (95% CI, 0.05-0.83; P ¼ 0.03) higher viral load, measured 4-24 months after infection, as compared to women with early viral homogeneity. In this multivariate linear regression analysis, the presence of GTI and the use of HC at the time of infection were not associated with a higher plasma viral load.
Discussion
This prospective study of 156 women showed that factors present at the time of infection influenced the genetic complexity of the transmitted HIV-1 population. There was a strong association between the genetic diversity of the infecting virus population and the use of HC and the presence of GTI around the time of HIV-1 acquisition. This is the first study that demonstrates that modifiable factors present at the time of HIV-1 transmission influence HIV-1 diversity as well as associated virus host dynamics. Early viral diversity was not associated with sexual exposure measurements such as sexual frequency or condom use suggesting that the observed associations with GTI and HC use are not because these are surrogate markers of increased sexual activity or lack of condom use in women who acquired multiple viruses. These results further support the idea that GTI and HC increase the susceptibility to HIV-1 acquisition because both the risk of infection and infection by more than one virus may be indicative of enhanced susceptibility.
We had previously shown that HC use and early viral diversity were both associated with higher viral set point [4, 17] . Here we showed that the presence of multiple viral variants, above and beyond the effects of HC and GTI, was associated with higher plasma viral set point. GTI and HC were not independent predictors of higher steady state plasma HIV-1 level. This suggests that GTI and HC may facilitate the number of viruses that can productively infect a host, and the resulting infection with multiple variants increases the level of HIV-1 replication.
While both GTI and HC change the physiology of the genital mucosa, it is unknown whether these factors affect the 'selective barrier' during heterosexual HIV-1 transmission by the same mechanism. One possibility is that they may both cause disruption of the vaginal epithelium, which could facilitate viral penetration either due to micro-ulcerations from genital infections, or due to thinning from the effects of progesterone, as suggested by studies in macaques [18] . Alternatively, both factors may directly promote virus-host cell interactions required for a productive infection. GTI produce a localized inflammatory response that may increase the number of cells susceptible to HIV-1 and/or affect the cytokines expressed in genital secretions [5, 7] . Because hormones regulate gene expression, they may enhance receptor/co-receptor expression on target cells, change cytokine levels, or alter lymphocyte migration or maturation [19] [20] [21] .
These studies indicate that the use of HC and the presence of GTI at the time of HIV-1 acquisition increase the susceptibility of women to infection by multiple HIV-1 variants. Previous studies suggest that the presence of multiple variants is not due to de novo variation in the host [1, 3] , suggesting that the observed effects of HC and GTI is on the acquisition of viruses or on their initial dissemination in the new host. In the future, it will be important to characterize the mechanisms by which these modifiable factors influence the 'selective barrier' to HIV-1 transmission.
